ALP
AlphaTON Capital Corp.
NASDAQ · Healthcare · Biotechnology · VG
$0.10
−13.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.06x
- Price / sales
- 79.25x
- Price / cash flow
- -0.24x
Enterprise value
- Enterprise value
- $5.3M
- EV / sales
- 54.87x
- EV / EBITDA
- -0.16x
- EV / EBIT
- -0.22x
- Market cap
- $7.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026